Photos

Disclaimer: the images on this website are for news media use only. If you have comments or questions, please do not hesitate to contact us.

The images in the patient category may not be used in relation to product information.


Anne Marie Kverneland, employee representativeAnne Marie Kverneland, employee representative


Download High Res
Download Low Res

Cities Changing Diabetes, MexicoCities Changing Diabetes, Mexico

Cities Changing Diabetes, Mexico 2014. At Ángel de la independencia
Download High Res
Download Low Res

New research and development facility in Bagsværd, DenmarkNew research and development facility in Bagsværd, Denmark

CMC Supply (Chemistry, Manufacturing and Control Supply), expected to be operational end 2016
Download High Res
Download Low Res

Cities Changing Diabetes, MexicoCities Changing Diabetes, Mexico

Cities Changing Diabetes, Mexico 2014. At Av. Pino Suárez
Download High Res
Download Low Res

Cities Changing Diabetes, Mexico 2014Cities Changing Diabetes, Mexico 2014

Cities Changing Diabetes, Mexico 2014. From Vista Poniente
Download High Res
Download Low Res

FlexTouch<span class="sup">®</span>FlexTouch®

FlexTouch® is the latest prefilled device from Novo Nordisk; the only prefilled insulin pen with no push-button extension.
Download High Res
Download Low Res

Needle production in Hjørring, DenmarkNeedle production in Hjørring, Denmark

Needle Manufacturing & Sourcing in Hjørring is responsible for the global manufacture of NovoFine®, NovoFine® Autocover®, NovoTwist® and NovoFine® Plus
Download High Res
Download Low Res

Oral insulin tabletsOral insulin tablets


Download High Res
Download Low Res

Needle manufacturing plan in Hjørring, DenmarkNeedle manufacturing plan in Hjørring, Denmark

Needle Manufacturing & Sourcing in Hjørring is responsible for the global manufacture of NovoFine®, NovoFine® Autocover®, NovoTwist® and NovoFine® Plus
Download High Res
Download Low Res

Needle production in Hjørring, DenmarkNeedle production in Hjørring, Denmark

Needle Manufacturing & Sourcing in Hjørring is responsible for the global manufacture of NovoFine®, NovoFine® Autocover®, NovoTwist® and NovoFine® Plus
Download High Res
Download Low Res

Needle production in Hjørring, DenmarkNeedle production in Hjørring, Denmark

Needle Manufacturing & Sourcing in Hjørring is responsible for the global manufacture of NovoFine®, NovoFine® Autocover®, NovoTwist® and NovoFine® Plus
Download High Res
Download Low Res

Oral insulin tabletOral insulin tablet


Download High Res
Download Low Res

Oral insulin tabletsOral insulin tablets


Download High Res
Download Low Res

NovoFine<span class="sup">®</span> PlusNovoFine® Plus

Ultra-thin, ultra-short universal pen needle. The shortest needle Novo Nordisk has ever made.
Download High Res
Download Low Res

Research and Develpment at Novo Nordisk in Måløv, DenmarkResearch and Develpment at Novo Nordisk in Måløv, Denmark


Download High Res
Download Low Res

Cameron Hubbard, USACameron Hubbard, USA

Cameron has type 1 diabetes
Download High Res
Download Low Res

Nina Oldenburg, GermanyNina Oldenburg, Germany

Nina Oldenburg has type 1 diabetes
Download High Res
Download Low Res

Bruno AngeliciBruno Angelici


Download High Res
Download Low Res

Sude Iğdır, TurkeySude Iğdır, Turkey

Sude Iğdır has type 1 diabetes
Download High Res
Download Low Res

Göran Ando, ChairmanGöran Ando, Chairman


Download High Res
Download Low Res

NovoMix®30 FlexPen® without capNovoMix®30 FlexPen® without cap


Download High Res
Download Low Res

Hannu Ryöppönen, member of the Audit CommitteeHannu Ryöppönen, member of the Audit Committee


Download High Res
Download Low Res

NovoMix®30 FlexPen®NovoMix®30 FlexPen®


Download High Res
Download Low Res

Rutha Gordon, USARutha Gordon, USA

Rutha has type 2 diabetes
Download High Res
Download Low Res

Nancy Johnson, USANancy Johnson, USA

Nancy has type 2 diabetes
Download High Res
Download Low Res

Henrik GürtlerHenrik Gürtler


Download High Res
Download Low Res

Peter Rot, GermanyPeter Rot, Germany

Peter Roth has type 2 diabetes
Download High Res
Download Low Res

Jeppe Christiansen, Vice ChairmanJeppe Christiansen, Vice Chairman


Download High Res
Download Low Res

Jay Luckey, USAJay Luckey, USA

Jay has haemophilia B
Download High Res
Download Low Res

Guillermo Nicolás Pirazzini, ArgentinaGuillermo Nicolás Pirazzini, Argentina

Guillermo Nicolás Pirazzini has haemophilia A
Download High Res
Download Low Res

Liz Hewitt, member of the Audit CommitteeLiz Hewitt, member of the Audit Committee


Download High Res
Download Low Res

Kazuyoshi Aoki, JapanKazuyoshi Aoki, Japan

Kazuyoshi Aoki has haemophilia A
Download High Res
Download Low Res

Søren Thuesen Pedersen, employee representativeSøren Thuesen Pedersen, employee representative


Download High Res
Download Low Res

Stig Strøbæk, employee representativeStig Strøbæk, employee representative


Download High Res
Download Low Res

Thomas Paul KoestlerThomas Paul Koestler


Download High Res
Download Low Res

Ulrik Hjulmand-Lassen, employee representativeUlrik Hjulmand-Lassen, employee representative


Download High Res
Download Low Res

Novo Nordisk Inflammation Research Center and Novo Nordisk Type 1 Diabetes R&D Center in Seattle, USNovo Nordisk Inflammation Research Center and Novo Nordisk Type 1 Diabetes R&D Center in Seattle, US


Download High Res
Download Low Res

Novo ScholarshipsNovo Scholarships

In January 2013 Novo Scholarships totalling 2,6 million Danish kroner were awarded to 41 of the country’s most talented MSc students in the biotechnological and pharmaceutical sciences
Download High Res
Download Low Res

Research and development at Novo Nordisk R&D Centre China in Beijing, ChinaResearch and development at Novo Nordisk R&D Centre China in Beijing, China


Download High Res
Download Low Res

New Novo Nordisk R&D Centre China in Beijing, China.New Novo Nordisk R&D Centre China in Beijing, China.


Download High Res
Download Low Res

New Novo Nordisk R&D Centre China in Beijing, China.New Novo Nordisk R&D Centre China in Beijing, China.


Download High Res
Download Low Res

Degludec molecule - Novo NordiskDegludec molecule - Novo Nordisk


Download High Res
Download Low Res

Research and development at Novo Nordisk R&D Centre China in Beijing, ChinaResearch and development at Novo Nordisk R&D Centre China in Beijing, China


Download High Res
Download Low Res

NovoPen<span class="sup">®</span> 4NovoPen® 4

NovoPen® 4 is a durable insulin pen which allows patients to change their insulin cartridge whilst retaining the same pen. 2010 is the 25th anniversary for NovoPen® which was the first insulin pen ever produced.
Download High Res
Download Low Res

NovoPen Echo<span class="sup">®</span>NovoPen Echo®

Insulin pen specifically designed to meet the needs of children with diabetes. First ever insulin pen to offer a combination of a memory function with a half-unit dosing option. Will be launched in 2010.


Download High Res
Download Low Res

NovoPen Echo<span class="sup">®</span> SkinsNovoPen Echo® Skins

An additional feature of the NovoPen® Echo is the option of customising the look of the pen with a number of colourful skins. Will be launched in 2010.


Download High Res
Download Low Res

NovoTwist<span class="sup">TM</span>NovoTwistTM

New needle designed for use with the insulin delivery device FlexPen® and Victoza® Pen. The needle, which has a simple ‘just twist’ attachment and detachment, makes injection easier for people with diabetes.


Download High Res
Download Low Res

Research and development of liraglutide at Novo Nordisk in Bagsværd, DenmarkResearch and development of liraglutide at Novo Nordisk in Bagsværd, Denmark


Download High Res
Download Low Res

Liraglutide molecule - Novo NordiskLiraglutide molecule - Novo Nordisk


Download High Res
Download Low Res

Mads Krogsgaard ThomsenMads Krogsgaard Thomsen

Executive vice president and chief science officer (CSO)


Download High Res
Download Low Res

Pen devicePen device


Download High Res
Download Low Res

NovoFine<span class="sup">®</span>NovoFine®

NovoFine® Autocover® was the world's first safety pen needle, designed to help prevent accidental needlestick injuries.


Download High Res
Download Low Res

InnoLet<span class="sup">®</span>InnoLet®

Has been designed specifically for people with poor eyesight, reduced manual dexterity or learning difficulties to better enable them to manage insulin therapy.


Download High Res
Download Low Res

HaemophiliaHaemophilia

Treatment of haemophilia patient.


Download High Res
Download Low Res

Cartridecacog moleculeCartridecacog molecule


Download High Res
Download Low Res

mAb2021 moleculemAb2021 molecule


Download High Res
Download Low Res

N8-GP moleculeN8-GP molecule


Download High Res
Download Low Res

N9-GP moleculeN9-GP molecule


Download High Res
Download Low Res

Turoctocog moleculeTuroctocog molecule


Download High Res
Download Low Res

NovoSeven<span class="sup">®</span> prefilled syringeNovoSeven® prefilled syringe


Download High Res
Download Low Res

R&D, haemophiliaR&D, haemophilia


Download High Res
Download Low Res

Lars Rebien SørensenLars Rebien Sørensen

President and Chief Executive Officer (CEO)
More photos
CV
Download High Res
Download Low Res

R&D, haemophiliaR&D, haemophilia


Download High Res
Download Low Res

R&D, haemophiliaR&D, haemophilia


Download High Res
Download Low Res

Team Novo NordiskTeam Novo Nordisk


Download High Res
Download Low Res

Team Novo NordiskTeam Novo Nordisk


Download High Res
Download Low Res

Team Novo NordiskTeam Novo Nordisk


Download High Res
Download Low Res

CartridgesCartridges


Download High Res
Download Low Res

Collecting crystalsCollecting crystals


Download High Res
Download Low Res

FlexTouch<span class="sup">®</span> Tresiba<span class="sup">®</span> fillingFlexTouch® Tresiba® filling


Download High Res
Download Low Res

Insulin degludec R&D, DenmarkInsulin degludec R&D, Denmark

Insulin degludec researchers Ib Jonassen and Svend Havelund
Download High Res
Download Low Res

Insulin degludec R&D, DenmarkInsulin degludec R&D, Denmark


Download High Res
Download Low Res

Insulin degludec R&D, DenmarkInsulin degludec R&D, Denmark


Download High Res
Download Low Res

Assembly lineAssembly line

Tresiba® in FlexTouch®
Download High Res
Download Low Res

VialsVials


Download High Res
Download Low Res

Kåre SchultzKåre Schultz

President and Chief Operating Officer (COO)
More photos
CV
Download High Res
Download Low Res

Jesper BrandgaardJesper Brandgaard

Executive Vice President and Chief Financial Officer (CFO)
More photos
CV
Download High Res
Download Low Res

Lars Fruergaard JørgensenLars Fruergaard Jørgensen

Executive vice president and chief information officer (CIO)
CV
Download High Res
Download Low Res

Lise KingoLise Kingo

Executive Vice President and Chief Of Staffs (COS)
More photos
CV
Download High Res
Download Low Res

Jakob RiisJakob Riis

Executive Vice President, Marketing & Medical Affairs
CV
Download High Res
Download Low Res

Mads Krogsgaard ThomsenMads Krogsgaard Thomsen

Executive Vice President and Chief Science Officer (CSO)
More photos
CV
Download High Res
Download Low Res

Research and development at Novo Nordisk Inflammation Research Center in Seattle, USResearch and development at Novo Nordisk Inflammation Research Center in Seattle, US


Download High Res
Download Low Res

Research and development at Novo Nordisk in Gentofte, DenmarkResearch and development at Novo Nordisk in Gentofte, Denmark


Download High Res
Download Low Res

Research and development of liraglutide at Novo Nordisk in Bagsværd, DenmarkResearch and development of liraglutide at Novo Nordisk in Bagsværd, Denmark


Download High Res
Download Low Res

Research and development at Novo Nordisk in Måløv, DenmarkResearch and development at Novo Nordisk in Måløv, Denmark


Download High Res
Download Low Res

Research and development at Novo Nordisk in Bagsværd, DenmarkResearch and development at Novo Nordisk in Bagsværd, Denmark


Download High Res
Download Low Res

Research laboratory at Novo Nordisk in Måløv, DenmarkResearch laboratory at Novo Nordisk in Måløv, Denmark


Download High Res
Download Low Res

Research and development at Novo Nordisk in Bagsværd, DenmarkResearch and development at Novo Nordisk in Bagsværd, Denmark


Download High Res
Download Low Res

Liraglutide<span class="sup">®</span> molecule - Novo NordiskLiraglutide® molecule - Novo Nordisk


Download High Res
Download Low Res

NordiPen<span class="sup">®</span>NordiPen®

With human growth hormone for treatment of growth disorders.


Download High Res
Download Low Res

New Novo Nordisk Corporate CentreNew Novo Nordisk Corporate Centre

The new Novo Nordisk Corporate Centre is expected to be ready for occupancy at the end of 2013. Illustration by Henning Larsen Architects.
Download High Res
Download Low Res

New Novo Nordisk Corporate CentreNew Novo Nordisk Corporate Centre

The new Novo Nordisk Corporate Centre is expected to be ready for occupancy at the end of 2013. Illustration by Henning Larsen Architects
Download High Res
Download Low Res

New Novo Nordisk Corporate CentreNew Novo Nordisk Corporate Centre

The new Novo Nordisk Corporate Centre is expected to be ready for occupancy at the end of 2013. Illustration by Henning Larsen Architects.
Download High Res
Download Low Res

Corporate headquartersCorporate headquarters

Novo Nordisk has its corporate headquarters in Bagsværd, Denmark.


Download High Res
Download Low Res

Corporate headquartersCorporate headquarters


Download High Res
Download Low Res

Novo Nordisk flagNovo Nordisk flag


Download High Res
Download Low Res

Corporate headquartersCorporate headquarters

Arial photo of Novo Nordisk headquarters in Bagsværd, Denmark.


Download High Res
Download Low Res

Novo Nordisk's dispensers for hormone tablets.Novo Nordisk's dispensers for hormone tablets.


Download High Res
Download Low Res

Hillerød, DenmarkHillerød, Denmark

Filling of modern insulin in vials in plant in Hillerød, Denmark.
Download High Res
Download Low Res

Tianjin, ChinaTianjin, China

Novo Nordisk's insulin plant


Download High Res
Download Low Res

Clayton, North Carolina, USAClayton, North Carolina, USA

Insulin manufacturing plant


Download High Res
Download Low Res

Montes Claros, BrazilMontes Claros, Brazil

Visual inspection of insulin vials, Brazil


Download High Res
Download Low Res

Hillerød, DenmarkHillerød, Denmark

Novo Nordisk's highly advanced plant in Hillerød, Denmark.


Download High Res
Download Low Res

Hillerød, DenmarkHillerød, Denmark

The NovoSeven® factory in Hillerød.


Download High Res
Download Low Res

Hillerød, DenmarkHillerød, Denmark

Arial photo of Novo Nordisk's plant in Hillerød, Denmark.


Download High Res
Download Low Res

Hillerød, DenmarkHillerød, Denmark

The production of Novo Nordisk's insulin pens takes place in the highly advanced plant in Hillerød, Denmark.

Download High Res
Download Low Res

Måløv, DenmarkMåløv, Denmark

Arial photo of Novo Nordisk's plant in Måløv, Denmark.

High res version is a ZIP file with a JPG file (1,22 Mb)
Low res version is a JPG file (6,334 Kb)

Download High Res
Download Low Res

Kalundborg, DenmarkKalundborg, Denmark

Packing of insulin pens in the plant in Kalundborg, Denmark.


Download High Res
Download Low Res

Kalundborg, DenmarkKalundborg, Denmark

Novo Nordisk's fermentation factory in Kalundborg, Denmark.


Download High Res
Download Low Res

Kalundborg, DenmarkKalundborg, Denmark

Arial photo of Novo Nordisk's fermentation factory in Kalundborg, Denmark.


Download High Res
Download Low Res

Kalundborg, DenmarkKalundborg, Denmark

Novo Nordisk's fermentation factory in Kalundborg, Denmark.


Download High Res
Download Low Res

August and Marie Krogh (1874-1949)August and Marie Krogh (1874-1949)

August Krogh a professor at the University of Copenhagen, received the Nobel Prize in physiology in 1920. His wife, Marie Krogh, was a doctor and a researcher in metabolic diseases.


Download High Res
Download Low Res

Hans Christian Hagedorn (1888-1971)Hans Christian Hagedorn (1888-1971)

and August Krogh founded Nordisk Insulinlaboratorium in 1923.


Download High Res
Download Low Res

Harald Pedersen (1878-1966)Harald Pedersen (1878-1966)

Harald Pedersen, an unusually talented inventor, founded Novo Terapeutisk Laboratorium together with his brother Thorvald Pedersen.


Download High Res
Download Low Res

Thorvald Pedersen (1887-1961)Thorvald Pedersen (1887-1961)

a qualified pharmacist, founded Novo Terapeutisk Laboratorium together with his brother Harald Pedersen in 1925.


Download High Res
Download Low Res

Insulin LeoInsulin Leo

Was Denmark’s first insulin product.


Download High Res
Download Low Res

Insulin NovoInsulin Novo


Download High Res
Download Low Res

The Novo syringe together with NovoPen<span class="sup">®</span>The Novo syringe together with NovoPen®

In 1925 Harald Pedersen designed a special syringe – the Novo syringe – with which the patients could inject themselves with insulin. In 1985 Novo Industri introduced the first NovoPen® (bottom).


Download High Res
Download Low Res

Insulin production at Novo in the 1930sInsulin production at Novo in the 1930s


Download High Res
Download Low Res

Production of insulinProduction of insulin

Some of the first machines for production of insulin at Novo.


Download High Res
Download Low Res

Changing Diabetes® in ChildrenChanging Diabetes® in Children

In December 2008, Novo Nordisk announced a five-year programme to change the future of children with type 1 diabetes in the least developed countries (LDCs). In November 2009, Bangladesh was added to the programme as the sixth country.


Download High Res
Download Low Res

Lotte Bjerre Knudsen at her laboratoryLotte Bjerre Knudsen at her laboratory

Lotte Bjerre Knudsen, who developed the liraglutide compound, pictured here in her laboratory at Novo Nordisk's R&D facility in Måløv, Denmark.


Download High Res
Download Low Res

Renewable energyRenewable energy

In May 2007, Novo Nordisk signed a partnership agreement with the Danish energy company DONG Energy. Under the partnership, Novo Nordisk pledges to convert all energy savings realised at its Danish production into the purchase of green electricity from the new offshore wind farm at Horns Rev in the North Sea.


Download High Res
Download Low Res

Renewable energyRenewable energy

With the partnership agreement Novo Nordisk has devised a cost-neutral way to significantly achieve reductions in CO2 emissions and help build the market for renewable energy in Denmark. When the wind farm is in full operation in 2010 it will secure Novo Nordisk’s Danish production a 100% green electricity supply and result in an annual CO2 reduction of 100,000 tons.


Download High Res
Download Low Res

Company BikesCompany Bikes

Company bikes make it possible for employees to commute at major Novo Nordisk sites in Denmark.
Download High Res
Download Low Res

Company Bikes Close UpCompany Bikes Close Up


Download High Res
Download Low Res

Company Bikes in useCompany Bikes in use


Download High Res
Download Low Res

NordiFlex<span class="sup">®</span> PensNordiFlex® Pens

The next generation of NordiFlex® represents the latest advance in prefilled growth hormone pens from Novo Nordisk.
Download High Res
Download Low Res

NordiFlex<span class="sup">®</span> PenmateNordiFlex® Penmate

NordiFlex PenMate® with automatic needle insertion accessory for users of NordiFlex® who prefer a hidden needle when injectin.
Download High Res
Download Low Res

NordiPen<span class="sup">®</span> CustomisedNordiPen® Customised

NordiPen® with human growth hormone for treatment of growth disorders.
Download High Res
Download Low Res

  •  

Our positions

The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.

Read more
eliminateiestendencies
  •